150
Participants
Start Date
October 30, 2018
Primary Completion Date
November 13, 2019
Study Completion Date
December 31, 2030
Medtronic TAVR Systems
Treatment of patients with bicuspid aortic anatomy and severe aortic stenosis at low risk for SAVR with Medtronic Evolut PRO and Evolut R systems
The Mount Sinai Hospital, New York
North Shore University Hospital, Manhasset
Saint Francis Hospital, Roslyn
UPMC Pinnacle Harrisburg Campus, Harrisburg
Paramount Heart, Villanova
Piedmont Atlanta Hospital, Atlanta
Tallahassee Memorial Hospital, Tallahassee
Morton Plant Hospital, Clearwater
HealthPark Medical Center, Fort Myers
OhioHealth Riverside Methodist Hospital, Columbus
University Hospitals Cleveland Medical Center, Cleveland
University of Michigan Health System, Ann Arbor
Spectrum Health Hospital, Grand Rapids
Mercy Medical Center - Des Moines, Des Moines
Aurora St. Luke's Medical Center, Milwaukee
Abbott Northwestern Hospital, Minneapolis
Baylor Jack and Jane Hamilton Heart & Vascular Hospital, Dallas
Houston Methodist Hospital, Houston
Abrazo Arizona Heart Hospital, Phoenix
Los Robles Hospital & Medical Center, Thousand Oaks
Scripps Memorial Hospital La Jolla, La Jolla
Oregon Health & Science University Hospital, Portland
Yale New Haven Hospital, New Haven
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Lead Sponsor
Medtronic Cardiovascular
INDUSTRY